Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
PubMed
16809314
PubMed Central
PMC1489063
DOI
10.1128/jvi.02694-05
PII: 80/14/7089
Knihovny.cz E-zdroje
- MeSH
- bezbuněčný systém MeSH
- genom virový fyziologie MeSH
- genové produkty gag genetika metabolismus MeSH
- HIV-1 izolace a purifikace fyziologie ultrastruktura MeSH
- kapsida metabolismus ultrastruktura MeSH
- konformace proteinů MeSH
- lidé MeSH
- Masonův-Pfizerův opičí virus izolace a purifikace fyziologie MeSH
- mutace MeSH
- oligonukleotidy genetika metabolismus MeSH
- RNA ribozomální genetika metabolismus MeSH
- RNA virová genetika metabolismus ultrastruktura MeSH
- sestavení viru fyziologie MeSH
- terciární struktura proteinů genetika MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- genové produkty gag MeSH
- oligonukleotidy MeSH
- RNA ribozomální MeSH
- RNA virová MeSH
In contrast to other retroviruses, Mason-Pfizer monkey virus (M-PMV) assembles immature capsids in the cytoplasm. We have compared the ability of minimal assembly-competent domains from M-PMV and human immunodeficiency virus type 1 (HIV-1) to assemble in vitro into virus-like particles in the presence and absence of nucleic acids. A fusion protein comprised of the capsid and nucleocapsid domains of Gag (CANC) and its N-terminally modified mutant (DeltaProCANC) were used to mimic the assembly of the viral core and immature particles, respectively. In contrast to HIV-1, where CANC assembled efficiently into cylindrical structures, the same domains of M-PMV were assembly incompetent. The addition of RNA or oligonucleotides did not complement this defect. In contrast, the M-PMV DeltaProCANC molecule was able to assemble into spherical particles, while that of HIV-1 formed both spheres and cylinders. For M-PMV, the addition of purified RNA increased the efficiency with which DeltaProCANC formed spherical particles both in terms of the overall amount and the numbers of completed spheres. The amount of RNA incorporated was determined, and for both rRNA and MS2-RNA, quantities similar to that of genomic RNA were encapsidated. Oligonucleotides also stimulated assembly; however, they were incorporated into DeltaProCANC spherical particles in trace amounts that could not serve as a stoichiometric structural component for assembly. Thus, oligonucleotides may, through a transient interaction, induce conformational changes that facilitate assembly, while longer RNAs appear to facilitate the complete assembly of spherical particles.
Zobrazit více v PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None PubMed
None
None PubMed
None PubMed
None PubMed
None PubMed
PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles
A simple, high-throughput stabilization assay to test HIV-1 uncoating inhibitors
In vitro methods for testing antiviral drugs
Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging
Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles
In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV
Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro